208 related articles for article (PubMed ID: 16611099)
1. Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects.
Lenato GM; Guanti G
Curr Pharm Des; 2006; 12(10):1173-93. PubMed ID: 16611099
[TBL] [Abstract][Full Text] [Related]
2. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.
Berg J; Porteous M; Reinhardt D; Gallione C; Holloway S; Umasunthar T; Lux A; McKinnon W; Marchuk D; Guttmacher A
J Med Genet; 2003 Aug; 40(8):585-90. PubMed ID: 12920067
[TBL] [Abstract][Full Text] [Related]
3. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
[TBL] [Abstract][Full Text] [Related]
4. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
[TBL] [Abstract][Full Text] [Related]
5. Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.
Lenato GM; Suppressa P; Giordano P; Guanti G; Guastamacchia E; Triggiani V; Amati L; Resta F; Covelli V; Jirillo E; Sabbà C
Curr Pharm Des; 2007; 13(36):3656-64. PubMed ID: 18220803
[TBL] [Abstract][Full Text] [Related]
6. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
Abdalla SA; Letarte M
J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
[TBL] [Abstract][Full Text] [Related]
7. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.
Letteboer TG; Mager JJ; Snijder RJ; Koeleman BP; Lindhout D; Ploos van Amstel JK; Westermann CJ
J Med Genet; 2006 Apr; 43(4):371-7. PubMed ID: 16155196
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.
Lesca G; Olivieri C; Burnichon N; Pagella F; Carette MF; Gilbert-Dussardier B; Goizet C; Roume J; Rabilloud M; Saurin JC; Cottin V; Honnorat J; Coulet F; Giraud S; Calender A; Danesino C; Buscarini E; Plauchu H;
Genet Med; 2007 Jan; 9(1):14-22. PubMed ID: 17224686
[TBL] [Abstract][Full Text] [Related]
10. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
[TBL] [Abstract][Full Text] [Related]
11. Molecular defects in rare bleeding disorders: hereditary haemorrhagic telangiectasia.
Shovlin CL
Thromb Haemost; 1997 Jul; 78(1):145-50. PubMed ID: 9198145
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of "Endoglin" and "Activin receptor-like kinase" genes in German patients with hereditary hemorrhagic telangiectasia and the value of rapid genotyping using an allele-specific PCR-technique.
Sadick H; Hage J; Goessler U; Stern-Straeter J; Riedel F; Hoermann K; Bugert P
BMC Med Genet; 2009 Jun; 10():53. PubMed ID: 19508727
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.
Sabbà C; Pasculli G; Lenato GM; Suppressa P; Lastella P; Memeo M; Dicuonzo F; Guant G
J Thromb Haemost; 2007 Jun; 5(6):1149-57. PubMed ID: 17388964
[TBL] [Abstract][Full Text] [Related]
14. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.
Albiñana V; Recio-Poveda L; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2012 Jul; 108(1):41-53. PubMed ID: 22552254
[TBL] [Abstract][Full Text] [Related]
15. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.
Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Perez-Molino A; Morales C; Restrepo CM; Ramirez JR; Coto E; Lenato GM; Bernabeu C; Botella LM
Hum Mutat; 2006 Mar; 27(3):295. PubMed ID: 16470589
[TBL] [Abstract][Full Text] [Related]
16. Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.
Sadick H; Sadick M; Götte K; Naim R; Riedel F; Bran G; Hörmann K
Wien Klin Wochenschr; 2006 Mar; 118(3-4):72-80. PubMed ID: 16703249
[TBL] [Abstract][Full Text] [Related]
17. A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q.
Vincent P; Plauchu H; Hazan J; Fauré S; Weissenbach J; Godet J
Hum Mol Genet; 1995 May; 4(5):945-9. PubMed ID: 7633456
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary hemorrhagic telangiectasia. Report of a pediatric case].
Maaloul I; Aloulou H; Fourati H; Sfaihi L; Chabchoub I; Kamoun T; Mnif Z; Hachicha M
Arch Pediatr; 2014 Jul; 21(7):768-71. PubMed ID: 24935454
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations.
Bayrak-Toydemir P; McDonald J; Markewitz B; Lewin S; Miller F; Chou LS; Gedge F; Tang W; Coon H; Mao R
Am J Med Genet A; 2006 Mar; 140(5):463-70. PubMed ID: 16470787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
